Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04898894 |
|
Recruitment Status :
Recruiting
First Posted : May 24, 2021
Last Update Posted : March 7, 2024
|
Sponsor:
St. Jude Children's Research Hospital
Collaborators:
Karyopharm Therapeutics Inc
AbbVie
Gateway for Cancer Research
Information provided by (Responsible Party):
St. Jude Children's Research Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Actual Primary Completion Date : | July 12, 2023 |
| Estimated Study Completion Date : | July 2025 |